يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"(1"', وقت الاستعلام: 1.42s تنقيح النتائج
  1. 1
    Comparisons between tumor burden and other prognostic factors that influence survival of patients with non‐small cell lung cancer treated with immune checkpoint inhibitors

    المؤلفون: Tatsuya Nitawaki, Takuro Sakagami, Naoki Shingu, Yuko Sekido, Yuko Yasuda, Aiko Nakano, Kodai Kawamura, Yoshihiko Sakata, Yoshitomo Eguchi, Jumpei Hisanaga, Kazuya Ichikado, Miwa Iio

    المصدر: Thoracic Cancer, Vol 10, Iss 12, Pp 2259-2266 (2019)
    Thoracic Cancer

    مصطلحات موضوعية: Adult, Male, non‐small cell lung cancer, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Prognostic factor, Lung Neoplasms, Immune checkpoint inhibitors, Tumor burden, Immune checkpoint inhibitor, lcsh:RC254-282, Programmed cell death ligand 1, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Internal medicine, Biomarkers, Tumor, medicine, Humans, Molecular Targeted Therapy, prognostic biomarker, Lung cancer, Aged, Neoplasm Staging, Proportional Hazards Models, Aged, 80 and over, Receiver operating characteristic, business.industry, Proportional hazards model, Original Articles, General Medicine, Middle Aged, Prognosis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, Original Article, Female, Non small cell, business, tumor burden

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20055af3f9dbba302975d5fe1162123fTest
    https://doi.org/10.1111/1759-7714.13214Test


    أضف إلى المفضلة
  2. 2
    Molecular characterization of clinical responses to PD‐1/PD‐L1 inhibitors in non‐small cell lung cancer: Predictive value of multidimensional immunomarker detection for the efficacy of PD‐1 inhibitors in Chinese patients

    المؤلفون: Kai Wang, Xiangdong Zhou, Qi Wang, Xiaoxia Cui, Xiaoyu Zhang, Chunxue Bai, Li Zhang, Jian Zhang, Jianping Zhao, Peng Song, Xiaoju Zhang, Faguang Jin, Yao Yu, Li Bai, Xiaoli Zhu, Yanbin Zhou, Chengzhi Zhou

    المصدر: Thoracic Cancer

    مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, Adolescent, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Pembrolizumab, NSCLC, Multi‐omics, B7-H1 Antigen, Young Adult, Study Protocol, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, PD‐1/PD‐L1 inhibitor, Carcinoma, Non-Small-Cell Lung, PD-L1, Internal medicine, Biomarkers, Tumor, medicine, Humans, Molecular Targeted Therapy, predictive biomarker, Lung cancer, Aged, Response rate (survey), biology, business.industry, General Medicine, Immunotherapy, Middle Aged, medicine.disease, Clinical trial, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, biology.protein, Immunohistochemistry, Female, Nivolumab, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adb9f8018da18f4739ee639337e1c7efTest
    https://doi.org/10.1111/1759-7714.13078Test


    أضف إلى المفضلة
  3. 3
    Programmed cell death‐ligand 1 (PD‐L1) expression and fibroblast growth factor receptor 1 (FGFR1) amplification in stage III/IV lung squamous cell carcinoma (SQC)

    المؤلفون: Guo, Qinxiang, Sun, Yu, Yu, Sifan, Bai, Hua, Zhao, Jun, Zhuo, Minglei, Wang, Jie

    المصدر: Thoracic Cancer

    مصطلحات موضوعية: Adult, Male, China, Lung Neoplasms, Gene Amplification, FGFR1 amplification, Antineoplastic Agents, Platinum Compounds, Original Articles, Middle Aged, Survival Analysis, B7-H1 Antigen, Disease-Free Survival, stomatognathic diseases, Treatment Outcome, Carcinoma, Squamous Cell, squamous lung carcinoma, Humans, Original Article, Female, Receptor, Fibroblast Growth Factor, Type 1, PD‐L1 expression, Aged, Neoplasm Staging

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::8401d876a74fb5aac977137e4da4b5bbTest
    http://europepmc.org/articles/PMC5334288Test


    أضف إلى المفضلة
  4. 4
    Primary malignant melanoma of the esophagus: A retrospective analysis of clinical features, management, and survival of 76 patients

    المؤلفون: Lu Si, Chuanliang Cui, Xuan Wang, Lili Mao, Bixia Tang, Xinan Sheng, Bin Lian, Jun Guo, Zhihong Chi, Yan Kong, Xieqiao Yan

    المصدر: Thoracic Cancer
    Thoracic Cancer, Vol 10, Iss 4, Pp 950-956 (2019)

    مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Adult, Male, medicine.medical_specialty, Esophageal Neoplasms, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Antineoplastic Agents, lcsh:RC254-282, Adjuvant therapy, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Drug Therapy, Internal medicine, medicine, Humans, Molecular Targeted Therapy, Esophagus, Melanoma, Aged, Retrospective Studies, Aged, 80 and over, Chemotherapy, business.industry, melanoma of esophagus, Cancer, General Medicine, Immunotherapy, Original Articles, Middle Aged, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Survival Analysis, 030104 developmental biology, medicine.anatomical_structure, Treatment Outcome, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Cohort, Female, Original Article, immunotherapy, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::669bf5646d0bfabf9b0d04ce19f1388eTest
    https://pubmed.ncbi.nlm.nih.gov/30864295Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث